Evidence map›Paper›PMID 35900691›Full record

ReviewNeuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater2023

[Cannabis use in adolescents : Narrative Review and Position paper of the "Addiction Disorders in Adolescents" task force of the Austrian Society for Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy (ÖGKJP)].

Katrin Skala, Thomas Trabi, Martin Fuchs, Ralf Gössler, Christian-Wilhelm Haas-Stockmair, Nicole Kriechbaumer, Monika Leitner, Nora Ortner, Melanie Reiter, Christian Müller and 1 more

Open access · hybridAbstract readEnglish AbstractReviewConsensus Statement
In one paragraph

Review in Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Katrin SkalaUniv. Klinik für Kinder und Jugendpsychiatrie, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090, Wien, Österreich. katrin.skala@meduniwien.ac.at.
Thomas TrabiAbteilung für Kinder- und Jugendpsychiatrie, LKH Graz II, Graz, Österreich.
Martin FuchsUniv. Klinik für Kinder- und Jugendpsychiatrie, Medizinische Universität Innsbruck, Innsbruck, Österreich.
Ralf GösslerAbteilung für Kinder- und Jugendpsychiatrie, Klinik Floridsdorf, Floridsdorf, Österreich.
Christian-Wilhelm Haas-StockmairUniv. Klinik für Kinder- und Jugendpsychiatrie, Kepler Universiätsklinikum, Linz, Österreich.
Nicole KriechbaumerSucht- und Drogenkoordination Wien, Wien, Österreich.
Monika LeitnerPraxis für Kinder- und Jugendpsychiatrie, Graz, Österreich.
Nora OrtnerUniv. Klinik für Kinder- und Jugendpsychiatrie, Medizinische Universität Innsbruck, Innsbruck, Österreich.
Melanie ReiterUniv. Klinik für Kinder- und Jugendpsychiatrie, Medizinische Universität Innsbruck, Innsbruck, Österreich.
Christian MüllerAmbulatorium für Kinder- u. Jugendpsychiatrie, PSD Einsenstadt, Einsenstadt, Österreich.
Wolfgang WladikaAbteilung für Neurologie und Psychiatrie des Kindes- und Jugendalters, Klinikum Klagenfurt, Klagenfurt, Österreich.
Innsbruck Medical University · ATKepler Universitätsklinikum · ATKlinikum Klagenfurt · ATMedical University of Vienna · ATUniversitätsklinik für Kinder und Jugendpsychiatrie · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCannabis is the illegal drug most frequently used by Minors in Austria. Due to the gradual decriminalization and legalization that has taken place in many European countries in recent years, the ÖGKJP would like to take a balanced and scientifically based stand on the complex issue of cannabis use and abuse among young people.

methodsThe authors searched the medline for current studies using searches tailored to each specific subtopic. Furthermore, recognized compendiums were quoted.

resultsWhile occasional recreational use of cannabis in adults with completed brain maturation and no risk profile for mental disorders is likely to be relatively harmless, early initiation of use with regular use and the increasingly available, highly potent cannabis varieties can lead to explicit and sometimes irreversible neurocognitive brain dysfunction.

conclusionLegalisation of cannabis consumption for minors needs to be objected to due to the risks of the expected damage in the area of brain development. At the same time, however, it is important to establish sensible legal regulations in order to be able to adequately counteract the fact that over 30% of all European young people occasionally consume cannabis. We are also clearly recommending to not criminalize cannabis users and provide necessary support to vulnerable and addicted cannabis users.

Indexed as

CannabisIllicit DrugsAdolescentAdolescent PsychiatryAdultAustriaChildHumansPsychotherapyIllicit DrugsBrain developmentEpidemiologyMinorsSubstance useTherapy

Identifiers

PMID35900691
PMCPMC10703949
OpenAlexW4288426394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.